HOME | 中文 | ENGLISH
Home
About Us
Wuxi Beita
Changsha Beita
Cooperation Units
Intellectual Property
Academic Publications
Qualification
Products
Radioisotope Labeled Products
Stable Isotope Labeled Products
Services
Technology Advantages
Labeling Service
Detection and Analysis Services
Customers
News
Beita News
Industry News
Media coverage
Contact Us
Feedback
Information List
Wuxi Beta Pharmaceutical Technology Co., Ltd. Science and Technology Association was formally established
2021-11-29
无锡贝塔医药科技有限公司科学技术协会正式成立 11月16日下午,无锡贝塔医药科技有限公司召开科学技术协会成立大会,江阴市科协副主席杨红波、组宣部部长邱克玉,高新区科技局局长夏天华、副局长许磊及有关部门负责人和公司董事长李刚、总裁曹卫秋、CEO朱称古以及公司全体科技工作者参加了会议。 会上,贝塔医药科协筹备小组作了筹备工作汇报,江阴市科协组宣部部长邱克玉宣读了关于同意成立无锡贝塔医药科技有限公司科学技术协会的批复,与会代表审议并通过了贝塔医药科协章程和选举办法。大会选举产生了贝塔医药科协第一届委员会委员,并召开第一届委员会第一次会议选举产生了主席、副主席、秘书长人选,李刚董事长宣读有关人选。 市科协副主席杨红波对贝塔医药科协的成立表示祝贺,并为贝塔医药科协授牌。 会上,杨红波副主席对贝塔医药企业科协提出了三点期望:一要强化科技支撑,投身创新江阴建设。希望企业科协大力开展创新服务活动,组织广大科技工作者在本职岗位上创先争优、在科技攻关任务中勇挑重担,推动企业科技进步与创新发展,为江阴高质量发展提供源源不断的创新活力、创造动力。二要深化建家交友,提供优质精准服务。希望企业科协充分发挥优势,以对科创产业“时光不语、静待花开”的定力,以对人才团队“政策给力、服务贴心”的氛围,建好科技工作者之家,当好科技工作者之友,为科技工作者提供优质精准服务。三要发挥组织优势,构建高效科创生态。要加强对企业科协的日常管理和服务保障,为企业科协开展工作创造良好条件,支持企业科协开展各项活动,在打通科技成果转化“最后一公里”上发挥独特作用。 高新区科技局局长夏天华肯定了贝塔医药在科技创新方面做出的成绩及为高新区发展做出的贡献,他希望贝塔医药成立科协后:一要投身自主创新,在创新驱动发展中发挥作用。充分发挥企业在创新活动中的引导作用,有效整合创新力量;要充分发挥自身特长和优势,围绕企业发展积极建言献策,努力提出高质量的意见建议,多出好主意和“金点子”。二要壮大科技队伍,在创优人才成长环境中多出实招。把加强科技人才队伍建设作为强企之基、转型之要,在创新实践中发现人才、培养人才、凝聚人才、成就人才,让一切创新想法得到尊重、一切创新举措得到支持、一切创新才能得到发挥、一切创新成果得到肯定,在企业中切实形成人才辈出、人尽其才的生动局面。三要致力科普宣传,在提高员工科学素质中大显身手。以提高企业员工科学素质为己任,深入员工开展科普宣传教育活动,推广最新科研成果,努力争当科学知识的传播者、科学方法的实践者、科学思想的倡导者、科学精神的弘扬者,在企业中形成讲科学、爱科学、学科学、用科学的良好风尚。 新当选的贝塔医药科协主席朱称古在会上作了表态发言,表示将充分发挥企业科协的桥梁纽带作用,促进科技工作者之间的交流及人才培养,引导企业科技工作者积极创新争先,为江阴“产业更高端、创新更澎湃”做出新的更大贡献。新一届委员会将精诚团结、务实高效、与时俱进、开拓创新,争做勤于学习的模范、善于创新的模范、甘于奉献的模范,影响和带动公司广大科技工作者紧紧围绕公司打造碳-13(C13)领域国内龙头企业、碳-14(C14)领域国际龙头企业的目标战略,以及公司下达的年度生产经营、新项目建设、新品研发等各项具体目标任务,立足岗位,努力钻研,大胆创新,勤奋工作,自觉奉献,努力开创各条线工作的新局面,为早日实现公司的宏伟蓝图争做贡献,为江阴高质量发展做出我们科技工作者的贡献。 会后,贝塔医药科协第一届委员和与会领导合影留念。
Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation.
Lu Jun, vice chairman of Wuxi Association for Science and Technology, and his party came to Beta Medicine for investigation and investigation. On the morning of August 25, Lu Jun, vice chairman of Wuxi Association for Science and Technology, Yang Hongbo, vice chairman of Jiangyin Association for Science and Technology, and Xu Lei, deputy director of Jiangyin High-tech Zone Science and Technology Bureau, visited Jiangyin Yangzijiang Bioaccelerator Park to carry out on-site investigation of offshore bases and Haizhi bases. The first stop came to Beta Pharmaceuticals. Dr. Li Gang, representative of Wuxi Association for Science and Technology and chairman of Beta Pharmaceuticals, reported on the development of the company. Vice Chairman Lu Jun spoke highly of Beta Pharmaceuticals's focus on nuclear technology applications (isotopes) to build a carbon -14 industry chain, focusing on research and development, deep cultivation, filling the domestic gap, benefiting the country and the people, taking root downward in the first ten years, and starting to break through the development of these years. Science and technology associations at all levels should help enterprises build domestic and international technology exchange platforms to help enterprises develop better and faster. The leader of the Jiangyin Association for Science and Technology stated that Jiangyin organizes the selection of the "Top Ten Science and Technology Stars" every two years to commend outstanding scientific and technological workers and encourage enterprises to actively declare. At the same time, assist enterprises to hold domestic or international academic exchange meetings, so that scientific and technological talents can also access the most cutting-edge technical information in Jiangyin, and help enterprises retain talents.
How much radiation does the C14 breath test have?
2021-10-14
Good news! Wuxi Beta Pharmaceutical Technology Co., Ltd. was recognized as a "high-tech enterprise" for the third time"
2021-01-28
On January 22, 2021, the Office of the National High-tech Enterprise Certification Management Leading Group issued the "Reply on the Filing of the First Batch of High-tech Enterprises in Jiangsu Province in 2020" (Guo Ke Huo [2021] No. 39), Wuxi Beta Pharmaceutical Technology Co., Ltd. was recognized as a "high-tech enterprise" (ranked 4962). This is the third time that our company has been recognized as a "high-tech enterprise". Wuxi Beta Pharmaceutical Technology Co., Ltd. was founded in Jiangyin High-tech Zone on November 27, 2008 by Dr. Li Gang, winner of the second prize for national scientific and technological progress and an entrepreneurial talent studying in the United States. It is a high-tech private enterprise specializing in the research and development and industrialization of isotope labeling products and tracer technologies such as carbon -14(C14) and carbon -13(C13) in the field of nuclear technology application (isotope) in China, the main purpose is to apply the strategic nuclide C14 radioisotope labeling tracer technology to innovative medicine, pesticide research and development, biotechnology and medical testing. The company has 4000 square meters of isotope labeling laboratory, and has established research and development platforms such as the Nobel Prize Research Institute, "Jiangsu Enterprise Academician Workstation" and Jiangyin Beta Isotope Labeling Engineering Technology Research Center. It has 18 authorized technology patents and more than 400 isotope labeling products, most of which fill the gaps in China and some of which are international initiatives. The company has signed cooperation agreements with nuclear reactor units, domestic and foreign pharmaceutical and pesticide industry leaders, Cambridge isotope laboratory company of the United States, Swiss RCTRITECH company, etc., after more than ten years of technical research, it has created five "gold standard" products and technologies in the field of medicine and medical treatment. Especially in the field of C14 marking products and tracer technology, the localization of domestic C14 source materials has been realized for the first time, and the C14 marking of domestic innovative medicines and pesticides has been solved. C14 marking services have been provided to listed pharmaceutical and pesticide companies such as Hengrui Medicine, Koren Pharmaceutical and Lier Chemical, as well as dozens of leading pharmaceutical and pesticide metabolism units such as Shanghai Institute of Medicine, Chinese Academy of Sciences, Ecological Environment Research Center and Shenyang Institute of Chemical, widely praised by customers, it has doubled the growth of its main business for three consecutive years and established solutions for international shortages. The identification of "high-tech enterprise" is a recognition of Wuxi Beta's long-term focus on research and development and rapid growth. Beta people will forge ahead and make new achievements, making unique and important contributions to the development of innovative medicine, innovative pesticide and ecological environmental protection.
Our company was selected as a reserve enterprise for cultivating science and technology innovation board in Jiangyin city in 2020.
2020-04-30
[Good News] Wuxi Beta Approved Construction Project of Provincial Academician Workstation of Provincial Science and Technology Department and Education Department
2020-03-31
Congratulations to Wuxi Beta for Providing SH-1028 New Drug of Shenghe Pharmaceutical Co., Ltd. with Carbon 14 Isotope Labeling Service
2019-08-01
Congratulations to Wuxi Beta for providing the Koren Pharmaceutical KL060332 Capsule labeled with carbon 14 isotope, which has been accepted by the National Food and Drug Administration Clinical Trial Notice and FDA Drug Clinical Trial Application
2019-07-31
On July 25, 2019, Sichuan Kelun Pharmaceutical Co., Ltd., an A- share listed company, issued the notice on the company's KL060332 capsule obtaining clinical trial notice and the acceptance of SKB264 new drug clinical trial application. The innovative drug KL060332 capsule developed by the company's holding subsidiary Sichuan Kelun Botai Biopharmaceutical Co., Ltd. has obtained the clinical trial notice of the State Drug Administration, and the KLUSPharmaInc of the company's holding subsidiary. Has been submitted to the United States Food and Drug Administration (hereinafter referred to as FDA) antibody conjugate drugs (AntibodyD
Good news! The Party Branch of Wuxi Beta Pharmaceutical Technology Co., Ltd. was approved to be established.
2019-07-26
Recently, the Party Working Committee of Jiangyin High-tech Zone approved the establishment of the Party branch of Wuxi Beta Pharmaceutical Technology Co., Ltd., which is a major event and happy event in the history of the company's entrepreneurial development. Since then, Wuxi Beta has an excellent grasp and position for team building. In the next step, the Party branch of Wuxi Beta Pharmaceutical Technology Co., Ltd. will follow the "Articles of the Communist Party of China", "Regulations on the Work of the Communist Party of China (Trial)", and "Opinions of the Organization Department of the Jiangyin Municipal Committee of the Communist Party of China on Promoting the Construction of the" Jiyanghong "Pioneer Position Demonstration Project", "Jiangyin High-tech Zone" Two New "Organization Party Building Work Tackling Tackling Quality and Quality Action Plan" and other party regulations and policy documents, in
Wuxi Beta Won the Second Prize of China Jiangyin (High-tech Zone) Innovation and Entrepreneurship Competition in 2019
2019-06-17
In order to implement the innovation-driven development strategy, further promote "mass entrepreneurship and innovation", continuously expand the characteristic industries of the high-tech zone, accelerate the cultivation of innovative industrial clusters, continue to create an environment for innovation and entrepreneurship, and stimulate the vitality of innovation and entrepreneurship in the region, since May this year, Jiangyin Science and Technology and Talent work leading Group and Jiangyin National High-tech Zone jointly held the 2019 China Jiangyin (High-tech Zone) Innovation and Entrepreneurship Competition with the theme of Zhihui Jiangyin, the competition attracted more than 200 enterprises and teams from Beijing, Shanghai, Guangzhou, Shenzhen, Nanjing, Wuhan, Suzhou, Wuxi and other places. Wuxi Beta
● Beita News
● Industry News
● Media coverage